Funding for this research was provided by:
Salix Pharmaceuticals (study support, funding for technical editorial assistance)
Received: 23 April 2020
Accepted: 12 January 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: This was an adult patient satisfaction post-marketing survey. Completion of the survey was voluntary, no medical records or other private information were obtained or reviewed, and no intervention or interaction with patients, related to the survey, was conducted. The sponsor determined that no external ethics approval was required (ie, exempt). Online consent to participate was provided by each patient as part of completion of the survey, as well as confirmation that they understood how the survey information would be used.
: Not applicable.
: BDC reports having served as a speaker, consultant, and advisory board member for Salix Pharmaceuticals. MBCM is an employee of Synchrony Medical Communications, LLC, an organization that has received funding from Salix Pharmaceuticals for manuscript development. MSE reports having nothing to disclose. DMP reports serving as a consultant and educator for Olympus Medical.